Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV003619150 | SCV004565302 | likely pathogenic | Severe X-linked myotubular myopathy | 2023-08-09 | criteria provided, single submitter | clinical testing | The MTM1 c.114del; p.Pro39GlnfsTer5 variant, to our knowledge, is not reported in the medical literature or gene specific databases. This variant is also absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. This variant causes a frameshift by deleting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be likely pathogenic. |
Labcorp Genetics |
RCV003619150 | SCV005843717 | pathogenic | Severe X-linked myotubular myopathy | 2025-01-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro39Glnfs*5) in the MTM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MTM1 are known to be pathogenic (PMID: 9305655, 10063835). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MTM1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2920995). For these reasons, this variant has been classified as Pathogenic. |